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Background and Purpose: Mucociliary clearance is an innate immune process of the
airways, essential for removal of respiratory pathogens. It depends on ciliary beat and
ion and fluid homeostasis of the epithelium. We have shown that nicotinic ACh
receptors (nAChRs) activate ion transport in mouse tracheal epithelium. Yet the
receptor subtypes and signalling pathways involved remained unknown.
Experimental Approach: Transepithelial short circuit currents (ISC) of freshly isolated
mouse tracheae were recorded using the Ussing chamber technique. Changes in [Ca2
+]i were studied on freshly dissociated mouse tracheal epithelial cells.
Key Results: Apical application of the nAChR agonist nicotine transiently increased
ISC. The nicotine effect was abolished by the nAChR antagonist mecamylamine.
α-Bungarotoxin (α7 antagonist) had no effect. The agonists epibatidine (α3β2, α4β2,
α4β4 and α3β4) and A-85380 (α4β2 and α3β4) increased ISC. The antagonists
dihydro-β-erythroidine (α4β2, α3β2, α4β4 and α3β4), α-conotoxin MII (α3β2) and
α-conotoxin PnIA (α3β2) reduced the nicotine effect. Nicotine- and epibatidine-
induced currents were unaltered in β2−/−mice, but in β4−/− mice no increase was
observed. In the presence of thapsigargin (endoplasmatic reticulum Ca2+-ATPase
inhibitor) or the ryanodine receptor antagonists JTV-519 and dantrolene there was a
reduction in the nicotine-effect, indicating involvement of Ca2+ release from intracel-
lular stores. Additionally, the PKA inhibitor H-89 and the TMEM16A (Ca2+-activated
chloride channel) inhibitor T16Ainh-A01 significantly reduced the nicotine-effect.
Conclusion and Implications: α3β4 nAChRs are responsible for the nicotine-induced
current changes via Ca2+ release from intracellular stores, PKA and ryanodine recep-
tor activation. These nAChRs might be possible targets to stimulate chloride trans-
port viaTMEM16A.
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1 | INTRODUCTION
Strict regulation of transepithelial ion transport is essential for effec-
tive mucociliary clearance. Mucociliary clearance represents a crucial
primary innate defence mechanism of the airways (Hollenhorst,
Richter, & Fronius, 2011; Knowles & Boucher, 2002). This is facili-
tated by beating of the cilia of ciliated epithelial cells and depending
on tightly controlled level and viscosity of the periciliary liquid
assured by appropriate regulation of transepithelial ion transport.
Several chronic airway diseases may be attributed to impaired
mucociliary clearance, including primary ciliary dyskinesia, cystic
fibrosis, asthma and chronic obstructive pulmonary disease (COPD)
(Dransfield et al., 2013; Knowles & Boucher, 2002). Disruption of
transepithelial ion transport is involved in severe pulmonary pheno-
types including impaired function of the cystic fibrosis
transmembrane conductance regulator in cystic fibrosis, chronic
obstructive pulmonary disease and cigarette smoke-induced chronic
bronchitis (Clunes et al., 2012; Dransfield et al., 2013; O'Sullivan &
Freedman, 2009).
In previous studies, we found a role for ACh released from non-
neuronal sources as a regulator of airway epithelial ion transport
(Hollenhorst, Lips, Weitz, et al., 2012; Hollenhorst, Lips, Wolff,
et al., 2012). Since the first studies of the non-neuronal cholinergic
system about 20 years ago (Grando, 1997; Sato et al., 1999; Wessler,
Kirkpatrick, & Racké, 1998), it is now well established that ACh plays
an important role as autocrine and paracrine signalling molecule in
diverse non-neuronal tissues, including the airway epithelium
(Hollenhorst et al., 2020; Perniss, Liu, et al., 2020). ACh transmits its
signals via two different classes of receptors: muscarinic (M1-5)
receptors and nicotinic receptors (nAChRs) (Lustig, 2006).
In the nervous system, nAChRs are well characterized. Generally,
nAChRs form heteropentameric or homopentameric ligand-gated ion
channels, permeable to Na+, K+ and Ca2+ (Wu, Cheng, Jiang, Melcher,
& Xu, 2015), that are composed of different subunits (α1–α10, β1–β4,
δ, ε and γ) (Lustig, 2006). Considerably less is known about their sub-
unit composition, stoichiometry, function and role in non-neuronal
cells. Several non-neuronal cells contain nAChR, including epithelial,
endothelial, cancer and immune cells (Grando, 1997; Kawashima &
Fujii, 2004; Macklin, Maus, Pereira, Albuquerque, & Conti-Fine, 1998;
Medjbera et al., 2015). Yet, in the last decade, there is increasing evi-
dence that nAChRs may additionally exert metabotropic actions, as
they increase the intracellular Ca2+ concentration without forming
Ca2+-permeable ion channels inT cells (Razani-Boroujerdi et al., 2007),
modulate ATP-induced Ca2+ release in rat alveolar macrophages
(Mikulski et al., 2010) and activate the Na+/K+ATPase via a protein
kinase C (PKC)-dependent pathway in rat colonic epithelium (Lottig,
Bader, Jimenez, & Diener, 2019). Additionally, metabotropic nAChRs
were found in monocytes (Richter et al., 2016) and airway epithelial
cell lines, where their activation inhibited ATP-mediated release of
IL-1β (Richter et al., 2018).
In mouse tracheal epithelium, nicotine binding to apical nAChRs
activates apical chloride secretion driven by basolateral potassium
secretion (Hollenhorst, Lips, Weitz, et al., 2012). However, the nAChR
subtype, the ionotropic or metabotropic nature of these receptors
and the ion channel subtypes facilitating the secretion of Cl− are
unknown. Here, we aim to identify the nAChR subtype as well as the
nAChR-activated channels responsible for the ion transport changes
and discuss whether this is a suitable target to activate chloride secre-
tion to restore mucociliary clearance.
2 | METHODS
2.1 | Compliance with requirements for studies
using animals
Animal studies are reported in compliance with the ARRIVE guidelines
(Percie du Sert et al., 2020) and with the recommendations made by
the British Journal of Pharmacology (Lilley et al., 2020). All animal care
and experimental procedures were approved by the German and
European animal welfare committee and performed according to the
German and European animal welfare law. Adult wild-type (WT,
C57Bl/6J, RRID:IMSR_JAX:000664) and β2−/− (Picciotto et al., 1995)
or β4−/− nAChR mice (Kedmi, Beaudet, & Orr-Urtreger, 2004) aged
between 10 and 15 weeks of both sexes were used throughout the
study. The β2−/− mice were backcrossed to C57Bl/6J for 12 genera-
tions and the β4−/− mice were backcrossed to C57Bl/6J for six gener-
ations after germline transmission. The animals were randomly chosen
once they had the appropriate age. The WT mice were bred and
What is already known
• Non-neuronal nicotinic ACh receptors activate chloride
secretion in mouse tracheal epithelium.
• α3β4 nicotinic receptors activate ciliary beat.
Wha this study adds
• α3β4 nicotinic receptors are essential for activation of
apical chloride secretion in the airways.
• Activation of α3β4 nicotinic receptors mediates Ca2+
release from intracellular stores and PKA-dependent
signalling.
What is the clinical significance
• α3β4 nAChR-dependent activation of Ca2+-dependent
chloride channel TMEM16A might be beneficial in cystic
fibrosis.
• Tracheal nicotinic ACh receptors might serve as possible
pharmaceutical targets to stimulate chloride transport.
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housed in IVC cages in the animal facility of the Institute of Experi-
mental Surgery of the Saarland University under standardized 12-h
day–night cycles with free access to food and water. β2−/− or β4−/−
nAChR mice were bred and held under specific pathogen-free condi-
tions in the animal facility of the Medical University of Vienna. After
shipping, these mice were housed in the animal facility of the Institute
of Experimental Surgery of the Saarland University for 2 weeks for
acclimatization and quarantine before the experiments were
performed.
2.2 | Materials
D-glucose, calcium D-gluconate, DMSO, ACh, ATP, mecamylamine,
NaHCO3, papaine, L-cysteine, leupeptine, pyruvic acid, NaOH and
tyrphostin AG490 (AG 490) were acquired from Sigma-Aldrich
(Taufkirchen, Germany). A-85380, α-bungarotoxin, α-conotoxin
PnIA, α-conotoxin MII, chelerythrine chloride, dihydro-
β-erythroidine (DHβE), epibatidine, T16Ainh-A01, Ani 9, CaCCinh-
A01, Chromanol293B, ACV 1 (conotoxin Vc1.1), dantrolene,
JTV519 and H-89 were obtained from Tocris Bioscience (Abingdon,
UK). The α-conotoxin ImI was ordered from Alomone Labs
(Jerusalem, Israel). KH2PO4, KCl and MgCl2 were purchased from
MERCK (Darmstadt, Germany). NaCl was ordered from Grüssing
GmbH (Westoverledingen, Germany). HEPES and BSA were from
Carl Roth (Karlsruhe, Germany). Thapsigargin and WP1066 were
acquired from Cayman Chemicals (Ann Arbor, MI, USA) and
nicotine from Glentham Life Sciences (Corsham, UK). EDTA and
Tween 20 were obtained from VWR (Darmstadt, Germany). Sodium
pyruvate was purchased from Gibco (Thermo Fisher Scientific,
Waltham, MA, USA) and DNase1 from Invitrogen (Thermo Fisher
Scientific).
2.3 | Ussing chamber experiments
For Ussing chamber measurements, mice were exposed to an over-
dose of the narcotic isoflurane and killed by aortic exsanguination.
The WT animals used for experiments with different agonists and
antagonists were randomly chosen. Experiments in which the
responses in WT animals were compared to knockout (KO) animals
were performed blinded. The trachea was immediately dissected and
the surrounding connective tissue was removed. Then the freshly iso-
lated tracheae were longitudinally opened by cutting the ventral mid-
line under the dissection microscope and mounted into a modified
Ussing chamber with a circular aperture of 1.8 mm2 as described pre-
viously (Hollenhorst, Lips, Wolff, et al., 2012). The tissue was continu-
ously perfused with buffer solution heated to 37C which had the
following composition (in mmolL−1):- 1.3 Ca2+ gluconate, 145 NaCl, 5
D-glucose, 5 HEPES, 1 MgCl2 and 2 KH2PO4 (pH 7.4). The Ag
+/AgCl
electrodes were linked with bridges of 2% agar and 3 molL−1 KCl to
the compartments of the Ussing chamber. The spontaneously gener-
ated transepithelial potential (VT) was clamped to 0 V with a voltage-
clamp amplifier (KU Leuven, Belgium) after an equilibration period of
approximately 5 min. The short circuit current (ISC) was continuously
recorded via a PowerLab version 4/35 (ADInstruments, Spechbach,
Germany) with LabChart version 8 (ADInstruments). All substances
were administered after an equilibration period of about 20 min. To
assure tissue viability, ATP (100 μmolL−1) was applied to the apical
side of the tissue at the end of each experiment. Tissues that did not
respond to ATP were not considered for data analyses.
2.4 | RT-PCR experiments
For RT-PCR experiments, the tracheal epithelium of WT mice was
scraped with a sterile cotton swab. The RNeasy Mini Kit (Qiagen,
Hilden, Germany) was used for RNA extraction according to the
manufacturer's instructions. Contaminating DNA was removed by
adding DNase-I (Invitrogen, Karlsruhe, Germany). Reverse transcrip-
tion of the RNA was performed using the superscript II reverse
transcriptase (Invitrogen) for 50 min at 42C and the cDNA was
amplified with specific intron-spanning primers (MWG, Ebersberg,
Germany, Table 1). Twenty-five microlitres of RT-PCR preparations
consisting of 2.5-μl buffer II, 2-μl MgCl2 (25 mmolL−1), 0.625-μl
dNTP (10 mmolL−1), 0.625-μl primer (20 pmolL−1), 0.125-μl
AmpliTaq Gold polymerase (5 Uμl−1, Applied Biosystems,
Branchburg, NJ, USA) and 2-μl cDNA supplemented with RNase-
free H2O were subjected an initial denaturation of 12 min at 95C
followed by cycles of 20 s at 95C, 45 s at a primer-specific
annealing temperature of 60C, 20 s at 72C and a final extension
of 7 min at 72C. Separation of the PCR products was performed
on a 1.25% TRIS-acetate-EDTA gel.
2.5 | Calcium imaging experiments
For isolation of tracheal epithelial cells for calcium imaging experi-
ments, randomly chosen mice were killed as described above. Then
the mouse tracheae were dissected into rings and transferred into
1-ml digestion media containing 1-ml Tyrode's I solution consisting of
(in mmolL−1) 140 NaCl, 10 glucose, 10 HEPES, 5 KCl, 1 MgCl2,
1 sodium pyruvate, 5 NaHCO3, supplemented with 2 mg of papaine
(10 Umg−1), 12 μmolL−1 L-cysteine, 0.5 μl of DNase1 and 4 μmolL−1
EDTA. The rings were digested for 40 min in a water bath at 37C.
Then they were removed from the solution and the solution was cen-
trifuged for 5 min at 900 g. The supernatant was removed and the cell
pellet resuspended in stop solution containing 1-ml Tyrode's II
(in mmolL−1: 140 NaCl, 10 HEPES, 10 glucose, 5 KCl, 1 MgCl2,
1 CaCl2, 1 sodium pyruvate and 1 pyruvic acid) and 2 μl of 10 mgml−1
leupeptin. The mix was kept for 5 min at room temperature and again
centrifuged for 5 min at 900 g. The supernatant was removed and the
cells were collected in 90-μl Tyrode's III buffer consisting of
(in mmolL−1) 130 NaCl, 10 glucose, 10 HEPES, 5 KCl, 8 CaCl2,
1 MgCl2, 10 sodium pyruvate and 5 NaHCO3. Thirty microlitres of the
cell suspension was added on a sterile coverslip coated with 285 μl of
0.1 molL−1 sodium bicarbonate, 5 μl of 1-N NaOH and 10 μl of
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Cell-Tak (Corning, New York, USA). Cells were incubated for
35–45 min at 37C on the coverslips and afterwards loaded with
100-μl Tyrode's III containing 4-μl Fura-2-AM (Invitrogen) and 2-μl
pluronic (Sigma-Aldrich) for 30 min at 37C. Before the start of the
measurements, coverslips were washed two times with Tyrode's III.
Fura-2-AM in the loaded cells was excited with a 340/380-nm ratio
of light from a DG4 wavelength switching xenon arc lamp (Sutter
Instruments, Novato, California, USA). For fluorescence detection, an
Orca Flash 4.0 camera was used (Hamamatsu, Herrsching, Germany).
Analyses were performed with the NIS-Elements software (Nikon
Instruments, Amsterdam, Netherlands).
2.6 | Experimental design and statistical analysis
The data and statistical analysis comply with the recommendations of
the British Journal of Pharmacology on experimental design and analy-
sis in pharmacology (Curtis et al., 2018). In the Ussing chamber experi-
ments, the values were calculated for 1-cm2 tissue area and reported
as mean ± SEM with the number (n) of the investigated tracheas and
animals. In all Ussing chamber experiments, a group size of n = 5–7
animals was designed. According to our previous experience, this was
identified as a suitable size to evaluate statistical significances
(Hollenhorst, Lips, Kummer, & Fronius, 2012; Hollenhorst, Lips, Weitz,
et al., 2012; Hollenhorst, Lips, Wolff, et al., 2012). For the calcium
imaging experiments, coverslips with cells isolated from at least five
different animals were measured with “N” denoting the number of
animals and “n” the number of cells evaluated. All data were first
analysed for normal distribution with the Kolmogorov–Smirnov test.
Afterwards, the paired or unpaired Student's t-test was applied when
data passed the normality test. Datasets that did not pass the
normality test were analysed with the Mann–Whitney U test. Statisti-
cal significance was assigned for P < 0.05.
2.7 | Nomenclature of targets and ligands
Key protein targets and ligands in this article are hyperlinked to
corresponding entries in the IUPHAR/BPS Guide to PHARMACOL-
OGY http://www.guidetopharmacology.org and are permanently
archived in the Concise Guide to PHARMACOLOGY 2019/20
(Alexander, Fabbro, et al., 2019, Alexander, Mathie, et al., 2019).
3 | RESULTS
3.1 | Nicotine activates transepithelial ion current
in WT mice
First, we characterized the basic effect of nicotine on transepithelial
ion transport. We applied nicotine on the apical side of the epithe-
lium, in order to investigate possible non-neuronal effects of
nAChRs. Apical application of 100 μmolL−1 nicotine transiently
increased ISC (20.09 ± 2.89 μAcm−2, Figure 1a,b). The nicotine
effect was dose dependent with an EC50 of 19.83 μmolL−1
(Figure 1c). When nicotine (100 μmolL−1, apical) was applied two
times repeatedly, the second nicotine-induced peak was significantly
smaller (of in total 6.11 ± 3.11 μAcm−2, Figure 1d), indicating a
desensitization. The nicotine effect was abolished by the general
nAChR antagonist mecamylamine (25 μmolL−1, reduction of
85.35%, Figure 1e,f), indicating that the nicotine-induced effect was
indeed due to an activation of nAChRs.
TABLE 1 Sequences of the primers used for RT-PCR experiments of the tracheal epithelium
nAChR subunit Accession no. Sequence Product length (bp)
α2 NM_144803 fwd: ctcccatcctgctttccag 115
rev: gtttgaacaggcggtcctc
α3 NM_145129 fwd: cgcctgttccagtacctgtt 196
rev: cagagggtttccatttcagc
α4 NM_015730 fwd: ctcagatgtggtccttgtcc 238
rev: ggtgggtgactgcaaagttc
α5 NM_176844 fwd: ccagctaatgaccaccaacg 218
rev: gctgcgtccaagtgacagt
α6 NM_021369 fwd: cctgcactgcggtttatgtc 231
rev: cagccacagattggtctcca
α7 NM_007390 fwd: acaatacttcgccagcacca 144
rev: aaaccatgcacaccagttca
α9 NM_001081104 fwd: caatgctctgcgtccagtag 208
rev: acaccagatcgctgggaa
α10 NM_001081424 fwd: tctgctcctgctctttctcc 207
rev: ccacaggtacaaggtcagca
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3.2 | Nicotine acts on heteromeric αβ nAChR
In the murine tracheal epithelium, we previously detected transcripts
for several nAChR subunits, comprising α3, α4, α5, α7, α9, α10, β2
and β4 (Hollenhorst, Lips, Weitz, et al., 2012). However, it remained
elusive, which receptor subtype is responsible for the observed ion
transport changes. Therefore, we here analysed the abundancy of the
different α nAChR subunits in every single epithelium of 18 different
mice via RT-PCR. The α3 and α10 subunits were present in 17 out of
18 epithelia, making them highly probable candidates for being
involved in the nicotine effect. Also, the α4 subunit with 14 out of
18 epithelia and the α7 subunit with 12 out of 18 epithelia showed
high distribution, while the α5 and α9 subunits were present only par-
tially (5 of 18 and 7 of 18, respectively) making them less likely candi-
dates (Table 2).
In the presence of the antagonist for solely α subunit containing
nAChRs (α7, α9 and α9α10, McIntosh, Absalom, Chebib, Elgoyhen, &
Vincler, 2009) α-bungarotoxin (100 nmolL−1), the nicotine effect
(100 μmolL−1, apical, at supramaximal dose) did not differ from con-
trol conditions (Figure 2a). Additionally, in the presence of the α7
nAChR antagonist α-conotoxin IMI (1 μmolL−1, apical) as well as the
α9α10 nAChR antagonist ACV 1 (100 nmolL−1, apical), the nicotine
effect was similar to control conditions (Figure 2a). Taken together,
these results indicate that neither α7, α9 nor α9α10 are involved in
the nicotine effect. Therefore, we next investigated the involvement
of mixed αβ heteromeric nAChRs in the nicotine effect and used dif-
ferent agonists and antagonists to identify possible α subunits. The
α4β2 and α3β4 agonist A-85380 (100 μmolL−1, Sullivan et al., 1996;
Whiteaker et al., 2002) led to a significant transient ISC increase
(39.27 ± 8.49 μAcm−2, Figure 2b) that was almost twice as large as
the nicotine effect. Similarly, epibatidine (1 μmolL−1), an α3β2, α4β2,
α4β4 and α3β4 nAChR agonist (Chavez-Noriega et al., 1997;
Stauderman et al., 1998) applied apically, led to a significant tran-
sient increase in ISC (41.76 ± 8.02 μAcm−2, Figure 2b). This effect
F IGURE 1 Effect of nicotine on
transepithelial ion transport of mouse tracheal
epithelium. (a) Apical application of nicotine
(100 μmolL−1) resulted in a transient increase in
short circuit current (ISC). Representative current
trace. (b) The nicotine-induced current increase
was significant compared to baseline (n = 5,
*P < 0.05). (c) The nicotine effect was dose
dependent (n = 5 for each concentration). (d)
Repeated apical nicotine application
(100 μmolL−1) in the same trachea showed a
reduced nicotine-activated current (ΔISC) upon
the second application (n = 5, *P < 0.05).
(e) Mecamylamine (25 μmolL−1, apical) abolished
the nicotine-induced ISC. Application of
mecamylamine did not influence ISC.
Representative current trace. (f) In the presence
of the non-selective nAChR antagonist
mecamylamine (MEC, 25 μmolL−1, apical),
nicotine had no significant effect on ISC (n = 5; ns,
not significant)
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was dose dependent with an EC50 of 65.47 nmolL−1 (Figure 2c),
indicating that the activated nAChRs were more sensitive to epi-
batidine than to nicotine. In the presence of 1 μmolL−1 dihydro-
β-erythroidine, an antagonist for α4β4, α4β2, α3β2 and α3β4 nAChRs
with decreasing affinity (Harvey & Luetje, 1996), the nicotine effect
was similar to control conditions (Figure 2d). Application of
10 μmolL−1 dihydro-β-erythroidine reduced the nicotine effect by
69.01% (Figure 2d), hinting to an involvement of α3 containing
nAChRs rather than α4 containing nAChRs in the nicotine effect.
The α3β2 antagonist α-conotoxin MII (Cartier et al., 1996) did not
influence the nicotine effect at a concentration of 50 nmolL−1
(Figure 2e), while it significantly reduced the nicotine effect
(by 60.56%) in a concentration of 1 μmolL−1 (Figure 2e). Another
α3β2 antagonist, α-conotoxin PnIA (Luo et al., 1999), did not influ-
ence the nicotine effect at a concentration of 100 nmolL−1, when
applied apically (Figure 2f), but at a concentration of 500 nmolL−1,
the nicotine effect was significantly reduced by 61.69% (Figure 2f).
This further indicates that nAChR responsible for the nicotine effect
contains the α3 subunit.
For characterization of the β subunit involved in the nicotine-
induced increase of the transepithelial ion current in the mouse tra-
cheal epithelium, Ussing chamber experiments were performed with
β2−/− and β4−/− nAChR mice. In β2−/− mice, the nicotine-induced
current (100 μmolL−1, apical) and the current induced by epi-
batidine (1 μmolL−1, apical) were similar to WT mice (Figure 3a–d).
In contrast to this, in β4−/− mice, the effect on ion transport
induced by 100 μmolL−1 nicotine and by 1 μmolL−1 epibatidine,
both applied apically, was completely abolished (Figure 3e–h), dem-
onstrating that the nAChR responsible for the ion transport
changes contains the β4 subunit and that this subunit is essential
for nicotine effect.
3.3 | The nicotine effect is associated with Ca2+-
and PKA-dependent intracellular signalling
To investigate if activation of tracheal epithelial nAChR leads to
a release of Ca2+ from intracellular stores, we performed
experiments with thapsigargin, an inhibitor of the Ca2+ ATPase in the
endoplasmatic reticulum (Thastrup, Cullen, Drobak, Hanley, &
Dawson, 1990). In the presence of 1 μmolL−1 thapsigargin, applied
apically, the nicotine effect was significantly reduced by 81.40%
(Figure 4a), indicating that the activation of the nicotine-induced ion
current changes is due to a release of Ca2+ from intracellular stores.
One signalling pathway leading to a release of Ca2+ from intracellular
stores, such as the endoplasmatic reticulum, is mediated by ryanodine
receptors (RyR1-3, Gerasimenko et al., 2006). Therefore, we next
aimed to elucidate if RyR are responsible for the nicotine effect in
mouse tracheal epithelium. We applied the antagonists JTV519
(10 μmolL−1) and dantrolene (10 μmolL−1) in order to inhibit all
RyR1-3 subtypes. Simultaneous application of these antagonists led
to the nicotine effect being completely abolished (Figure 4b). Because
an increase in intracellular Ca2+ may also activate other effector
proteins, such as the PKC which in turn is able to act on ion channels
(Cui et al., 2019; Wang et al., 2019), we investigated the influence of
PKC on the nicotine-induced ion current. Application of the PKC
inhibitor chelerythrine chloride (5 μmolL−1, apical and basolateral,
Herbert, Augereau, Gleye, & Maffrand, 1990) did not affect the
nicotine-induced current (Figure 4c). This indicates that Ca2+ released
through RyR does not activate PKC and, thus, PKC-activated
transport proteins.
Because Ca2+- and cAMP-dependent signalling pathways may be
interconnected, we further investigated the involvement of cAMP-
dependent signalling on the nicotine effect. Inhibition of the PKA with
the inhibitor H-89 (10 μmolL−1, apical and basolateral) significantly
reduced the nicotine effect by 74.08% (Figure 4d), indicating a role
for cAMP-dependent PKA activation.
Because some nAChRs have been shown to be coupled to the
JAK2–STAT3-dependent pathway before eliciting effects further
downstream (de Jonge et al., 2005; Hosur & Loring, 2011), we investi-
gated if this signalling pathway was also involved in the nicotine effect
in the signalling cascade before the release of Ca2+ from intracellular
stores. Application of the JAK2 inhibitor AG 490 (50 μmolL−1, apical
and basolateral, Meydan et al., 1996) or the STAT3 inhibitor WP1066
(10 μmolL−1, apical, Hussain et al., 2007) did not lead to a significant
change of the nicotine effect ( Figure 4e,f), indicating that the JAK2–
STAT3 signalling pathway is not involved in the nicotine-induced cur-
rent changes.
TABLE 2 Different α nicotinic ACh receptor subunits detected
with RT-PCR in mouse tracheal epithelium
Mouse α2 α3 α4 α5 α6 α7 α9 α10
1 - x x - - x x x
2 - x - - - x - x
3 - x x x - x x -
4 x x x - - x x x
5 - x x - - x - x
6 - x x - - x - x
7 - x x x - x - x
8 x x x - - x x x
9 - x x - - x - x
10 - x x x - x x x
11 - x x x - - x x
12 - x x - - - - x
13 - x x - - - - x
14 - x x x x - x x
15 - x x - - - - x
16 - - - - - x - x
17 - x - - - x - x
18 - x - - - - - x
Total 2 17 14 5 1 12 7 17
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3.4 | The nicotine effect is mainly mediated by
Ca2+ release from intracellular stores
To clarify if the nicotine effect involves Ca2+-permeable nAChRs or
metabotropic-mediated release of Ca2+ from intracellular stores, we
performed Ca2+ imaging experiments on freshly isolated mouse
tracheal epithelial cells. Experiments were carried out with Ca2+-
containing Tyrode's medium or Ca2+-free EGTA-containing Tyrode's
medium in order to achieve extracellular Ca2+-free conditions
(Figure 5a,b). In both cases, a significant increase in [Ca2+]i was
observed in the presence of nicotine, although the increase was signif-
icantly smaller in Ca2+-freeTyrode's (Figure 5c). This indicates that the
nAChRs in the tracheal epithelium are mainly, but not completely,
increasing [Ca2+]i via Ca
2+ release from intracellular stores rather than
via an influx of Ca2+ ions through the nAChRs themselves or via other
mechanisms such as voltage-gated Ca2+ channels in the plasma mem-
brane. In addition, it was noted that the same percentage of cells
(41%) were reacting to nicotine in experiments with and without
extracellular Ca2+, indicating that while the amplitude of the reaction
was reduced in Ca2+-free conditions, it did not affect the total number
of reacting cells.
3.5 | The chloride channel TMEM16A and the
potassium channel KCNQ1(Kv7.1) are involved in the
nicotine effect
Our previous study (Hollenhorst, Lips, Weitz, et al., 2012) indicated an
involvement of Ca2+-dependent chloride channels in the nicotine
effect. However, the exact identity of the activated chloride channel
responsible for the apical chloride secretion remained elusive. Here,
we performed experiments targeting the calcium-activated chloride
channel (CaCC) TMEM16A with the inhibitor T16Ainh-A01
(10 μmolL−1, Namkung, Phuan, & Verkman, 2011). In the presence of
T16Ainh-A01 apically, the nicotine effect was significantly reduced by
80% (Figure 6a,b). Also, another TMEM16A inhibitor Ani
9 (10 μmolL−1, apical) reduced the nicotine effect significantly by
77% (Figure 6c). In the presence of CaCCinh-A01 (100 μmolL−1, api-
cal), an inhibitor of CaCCs, the nicotine effect was completely
F IGURE 2 Effect of nicotinic receptor
agonists and antagonists on transepithelial ion
transport of mouse tracheal epithelium. (a) The α7
nicotinic ACh receptor (nAChR) antagonist
α-bungarotoxin (αBTX, 100 nmolL−1, n = 5,
apical) or the α7 nAChR antagonist α-conotoxin
ImI (C. ImI, 4 μmolL−1, apical) or the α9α10
nAChR antagonist ACV-1 (100 nmolL−1, apical)
did not influence the nicotine effect
(100 μmolL−1, apical, ΔISC; ns, not significant).
(b) The epibatidine-induced (α4β2, α3β2, α4β4 and
α3β4 nAChR agonist) current peak (1 μmolL−1)
was significant compared to baseline current
(n = 5, *P < 0.05). Application of the α4β2 and
α3β4 nAChR agonist A-85380 (100 μmolL−1,
apical, n = 5) significantly increased ISC (*P <
0.05). (c) The epibatidine effect was dose
dependent (n = 5 for each concentration). (d) In
the presence of 1 μmolL−1 of the α4β2, α3β2,
α4β4 and α3β4 nAChR antagonist dihydro-
β-erythroidine (DhβE), the nicotine effect (ΔISC)
was similar to control conditions (n = 5; ns, not
significant), but 10 μmolL−1 DhβE significantly
reduced the nicotine-induced current (ΔISC, n = 5,
*P < 0.05). (e) The α3β2 nAChR antagonist
α-conotoxin MII (C. MII) did not influence the
nicotine effect (ΔISC) in a concentration of
50 nmolL−1 (n = 5; ns, not significant) but
significantly reduced the nicotine-induced current
(ΔISC, n = 5, *P < 0.05) in a concentration of
1 μmolL−1. (f) The α3β2 antagonist α-conotoxin
PnIA (C. PnIA) did not influence the nicotine
effect (ΔISC) in a concentration of 100 nmolL−1
(n = 6; ns, not significant) but significantly reduced
the nicotine-induced current in a concentration of
500 mmolL−1 (ΔISC, n = 5, *P < 0.05)
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abolished (Figure 6d). These results identify the contribution of CaCCs
and specifically TMEM16A to the nicotine effect. Due to evidence
that PKA mediates in the nicotine effect (Figure 4d), we also
addressed the role of the PKA-activated potassium channel KCNQ1.
Inhibition of KCNQ1 with chromanol 293B (100 μmolL−1, basolateral)
significantly reduced the nicotine effect by 87% (Figure 6e). This indi-
cates that the nicotine-induced apical chloride secretion is driven by
activation of the basolateral potassium channel KCNQ1.
4 | DISCUSSION
We have recently shown that ACh plays an important role as a non-
neuronal autocrine and paracrine signalling molecule by increasing
mucociliary clearance in the mouse tracheal epithelium in response to
bacterial molecules (Hollenhorst et al., 2020). This is of considerable
importance and clinically relevant, as this mechanism provides an
effective response to remove inhaled pathogens. Using Ussing cham-
ber experiments, we have previously shown that in the mouse tra-
cheal epithelium functional nAChRs are expressed and that their
activation leads to a transient apical chloride secretion which is
dependent on a basolateral potassium secretion (Hollenhorst, Lips,
Weitz, et al., 2012). In the present study we have confirmed the find-
ings that application of nicotine leads to a transient current increase,
observing an EC50 of 19.83 μmolL−1. This is in agreement with obser-
vations in monkey bronchial epithelial cells, where the EC50 for nico-
tine was 26.5 μmolL−1 (Xiao, Lindstrom, & Spindel, 2009). Whereas in
recombinant human nAChR overexpressing Xenopus oocytes, EC50
F IGURE 3 Effect of nicotine or epibatidine
on transepithelial ion transport in β2- or
β4-deficient mice. (a) Apical application of
nicotine (100 μmolL−1) in β2−/− mice resulted in a
transient reversible increase in the short circuit
current (ISC). Representative current trace. (b) The
nicotine-induced peak (ΔISC) in β2−/− mice was
similar to wild-type (WT) mice (n = 5; ns, not
significant). (c) Apical application of epibatidine
(1 μmolL−1) in β2−/− mice resulted in a transient
reversible increase in ISC. Representative current
trace. (d) The epibatidine-induced peak (ΔISC) was
similar in WT and β2−/− mice (n = 5; ns, not
significant). (e) Apical application of nicotine
(100 μmolL−1) in β4−/− mice did not influence ISC.
Representative current trace. (f) The nicotine-
induced peak (ΔISC) in β4−/− mice was
significantly reduced compared to WT mice
(n = 5, *P < 0.05). (g) Apical application of
epibatidine (1 μmolL−1) in β4−/− mice had no
effect on ISC. Representative current trace. (h) The
epibatidine-induced peak (ΔISC) was significantly
reduced in β4−/− mice compared to WT mice
(n = 5, *P < 0.05)
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values for nicotine had a broad range from the lowest EC50 of
5.02 μmolL−1 for α4β4 nAChR to the highest EC50 of 132.44 μmolL−1
for α3β2 nAChR (Chavez-Noriega et al., 1997), showing that our EC50
is well in this range.
Our observation that α-bungarotoxin, α-conotoxin ImI and
ACV-1, antagonists for α7, α9 and α9α10 nAChR, did not alter the nic-
otine effect shows that these nAChR subtypes are not involved in the
nicotine effect and that rather mixed αβ heteromeric receptors are
responsible for the effect. Nevertheless, the α7 nAChR is expressed in
mouse tracheal epithelium as we have shown here and previously
(Hollenhorst, Lips, Weitz, et al., 2012). This receptor was found to
influence transepithelial ion transport by other mechanisms as it was
functionally coupled to cystic fibrosis transmembrane conductance
regulator activation (Maouche et al., 2013). The complete inhibition of
the nicotine effect by pretreatment with the non-selective nAChR
antagonist mecamylamine observed in present study supports the
conclusion that the nicotine-induced effect was indeed due to activa-
tion of heteromeric αβ nAChRs. Consistent with these observations,
desensitization was observed upon a second agonist application for
the αβ heteromeric nAChRs but not for the α7 nAChR (Chavez-
Noriega et al., 1997).
Indeed, the α3β2, α4β2, α4β4 and α3β4 nAChR agonist epi-
batidine and the α4β2 and α3β4 agonist A-85380 mimicked the nico-
tine effect in our study. In accordance with a study from Sullivan
et al. (1996), A-85380 was more potent than nicotine but less potent
than epibatidine. Dihydro-β-erythroidine, a competitive antagonist of
α4β2, α3β2, α4β4 and α3β4 nAChRs, significantly reduced the nicotine
effect in a concentration of 10 μmolL−1. The affinity of the antagonist
varies for the different nAChR subtypes with IC50 values of 1.3 μM
for the α2β2 nAChR, 2.3 μM for the α2β4 nAChR, 0.41 μM for the
α3β2 nAChR, 23.1 μM for the α3β4 nAChR, 0.37 μM for the α4β2
nAChR and 0.19 μM for the α4β4 nAChR (Harvey & Luetje, 1996).
The residual effect observed at 10 μmolL−1 and the fact that besides
α3β4 nAChRs all other α3 or α4 containing nAChR subtypes should
have already been blocked at a concentration of 1 μmolL−1 point
towards the α3β4 nAChR being responsible for the nicotine effect.
Also, our observation that the α3 subunit was present in almost all
epithelia analysed by PCR points to the α3 subunit as being responsi-
ble for the nicotine effect. Supportively, the α3β2 antagonists,
α-conotoxin MII and α-conotoxin PnIA only attenuated the nicotine
effect in doses much higher than their IC50 of 0.5 nM for MII (Cartier
et al., 1996) and 9.56 nM for PnIA (Luo et al., 1999), indicating that
they might also act on similar nAChR, such as the α3β4 receptor. This
is supported by our findings in β2−/− and β4−/− nAChR mice that
clearly demonstrate the β4 subunit is responsible for the nicotine
effect. The complete abolishment of the nicotine effect in β4−/−
nAChR mice is not due to reduced reaction caused by a deteriora-
tion of epithelial integrity as the epithelia still reacted to ATP that
was used to finale experiments as a viability control (data not
shown). Taken together, these results show that the α3β4 nAChR is
the subtype that activates transepithelial ion transport in the mouse
tracheal epithelium. In support of this, this receptor subtype has
recently been shown to transiently activate ciliary beat (Perniss,
Latz, et al., 2020), indicating that it is essential for the regulation of
F IGURE 4 Downstream signalling involved in
the nicotine-induced activation of transepithelial
ion transport in mouse trachea. (a) Application of
1-μM thapsigargin (THA, apical, n = 5), an inhibitor
of the Ca2+-ATPase in the endoplasmatic
reticulum, significantly reduced the nicotine effect
(100 μM, apical, ΔISC, *P < 0.05). (b) In the
presence of the ryanodine receptor antagonist
JTV519 and dantrolene (each 10 μmolL−1, apical),
nicotine (100 μmolL−1, apical) had no effect on
ISC (ns, not significant; n = 5). (c) The protein
kinase C (PKC) inhibitor chelerythrine chloride
(CC, 5 μmolL−1, apical and basolateral, n = 7) did
not influence the nicotine effect (100 μmolL−1,
apical, ΔISC; ns, not significant). (d) In the presence
of the protein kinase A (PKA) inhibitor H-89
(10 μmolL−1, apical and basolateral, n = 5), the
current induced by nicotine (100 μmolL−1, apical,
ΔISC, *P < 0.05) was significantly reduced.
(e) Application of the JAK2 inhibitor AG
490 (50 μmolL−1, apical and basolateral, n = 5) did
not lead to a significant change of the nicotine
effect (100 μmolL−1, apical, ΔISC, *P < 0.05). (f)
Application of the STAT3 inhibitor WP1066
(10 μmolL−1, apical, n = 6) did not influence the
nicotine effect (100 μM, apical, ΔISC; ns, not
significant)
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both components of mucociliary clearance, ciliary beat and airway
surface liquid regulation.
Additionally, in the present experiments we have elucidated the
nAChR downstream signalling cascades leading to the nicotine effect.
Previously, we have shown that the nicotine effect in the mouse tra-
cheal epithelium is mediated only to a small extend by Ca2+ influx
from extracellular sources into the cell and Na+ influx played no role
(Hollenhorst, Lips, Weitz, et al., 2012). In rat colonic epithelium, meta-
botropic nAChRs that activate Na+/K+-ATPase currents have been
reported (Bader, Lottig, & Diener, 2017; Lottig, Bader, Jimenez, &
Diener, 2019) revealing a mode of action that is independent from an
ionotropic action.
Our observation that the nicotine effect was reduced when the
release of intracellular Ca2+ from the intracellular stores was
inhibited by thapsigargin underlines the involvement of meta-
botropic nAChRs that act via the release of Ca2+ from the
endoplasmatic reticulum rather than forming ligand-gated ion chan-
nels. Additionally, our Ca2+ imaging results clearly show that stimu-
lation with nicotine leads to a [Ca2+]i increase in tracheal epithelial
cells due to a release of Ca2+ from intracellular stores, since the
same percentage of cells reacted to nicotine independently of
the extracellular Ca2+ concentrations. Furthermore, our results with
the RyR antagonists, JTV519 and dantrolene (Hunt et al., 2007;
Zhao, Li, Chen, Louis, & Fruen, 2001), demonstrate that Ca2+ is
released from the endoplasmatic reticulum via RyR. Taken together,
these results provide first evidence for metabotropic nAChR signal-
ling in mouse tracheal epithelium. Interestingly, the nicotine effect
seems to be mediated via RyR as well as IP3 receptors as we have
previously shown (Hollenhorst, Lips, Weitz, et al., 2012). RyR and
IP3 receptors are structurally related but are generally assumed to
have different physiological profiles (Santulli, Nakashima, Yuan, &
Marks, 2017).
Our findings of metabotropic nAChR add to the increasing evi-
dence for metabotropic nAChR signalling (Kabbani & Nichols, 2018).
In rat colonic epithelial cells, Lottig, Bader, Jimenez, and Diener (2019)
recently found that nAChRs activate the Na+/K+ATPase via cytosolic
increased Ca2+ and PKC. However, in the tracheal epithelium, we
could not find evidence for the involvement of PKC in response to
nicotine. Further, evidence for metabotropic activity of nAChRs inter-
fering with changes of [Ca2+]i was found in rat alveolar macrophages
(Mikulski et al., 2010). In these cells, nAChRs reduced ATP-induced
Ca2+ release and this was also independent of the presence of extra-
cellular Ca2+.
We have previously found an involvement of adenylyl
cyclase (AC) in the nicotine effect (Hollenhorst, Lips, Kummer, &
Fronius, 2012). Second messenger signalling can be interconnected,
for example, signalling by Ca2+ and cAMP, because there are calcium-
dependent ACs (Shahidullah, Mandal, & Delamere, 2017). Here, we
showed for the first time in non-neuronal cells that nAChRs activate
PKA, as the PKA inhibitor H-89 (Chijiwa et al., 1990) attenuated the
nicotine effect. So far, this has only been described for neurons,
where nicotine acts on γ oscillations in the rat hippocampus via PKA
(Wang et al., 2017). PKA involvement in the nicotine effect (Figure 7)
F IGURE 5 Ca2+ imaging and immunohistochemistry experiments
of tracheal epithelial cells of wild-type mice. (a) Application of
nicotine, ACh, or ATP significantly increased [Ca2+]i compared to
baseline in the presence of Ca2+-containing external solution (normal
Tyrode's). N, number of animals; n, number of cells. (b) Application of
nicotine, ACh, or ATP increased [Ca2+]i compared with baseline in the
presence of Ca2+-free external solution. N, number of animals; n,
number of cells. (c) The nicotine-induced [Ca2+]i was significantly
reduced in Ca2+-free buffer compared to extracellular Ca2+-containing
solution (Tyrode's)
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is further supported by our findings that KCNQ1 is involved in the
nicotine effect, as this channel is a phosphorylation target of PKA
downstream of cAMP activation (Marx et al., 2002).
Effectors of nAChR activation in mouse tracheal epithelium are
channels involved in chloride secretion (Hollenhorst, Lips, Weitz,
et al., 2012), but the type of channels involved remains unknown.
Interestingly, in the present study we observed the activation of the
Ca2+-activated chloride channel TMEM16A via nAChR signalling.
This is of particular importance, because targeting this channel has
been discussed as an alternative drug target to restore Cl− secretion
in cystic fibrosis patients due to defective cystic fibrosis transmem-
brane conductance regulator function (Danahay et al., 2020). The
observed transient increase in TMEM16A observed in our study
might also be beneficial in cystic fibrosis, since one study hypothe-
sized that a transient stimulation of chloride secretion is impaired in
cystic fibrosis (Song et al., 2009). Interestingly, non-neuronal cholin-
ergic signalling was down-regulated in cystic fibrosis patients
(Wessler et al., 2007), further underlining the putative beneficial
effects of targeting the nAChR signalling in airway epithelia, as
investigated in our study.
Taken together, our study identifies α3β4 nAChRs as the main
subunits responsible for the nicotine effect. The activation of which
leads to an increase of [Ca2+]i released from the endoplasmatic reticu-
lum and PKA activation. This [Ca2+]i increase in turn activates the
TMEM16A chloride channel. These nAChRs might represent a novel
pharmacological target to restore defective anion secretion in condi-
tions such as cystic fibrosis, chronic obstructive pulmonary disease
and cigarette smoke-induced chronic bronchitis and to improve
mucociliary clearance.
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